Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $278,491 | 61 | 75.7% |
| Travel and Lodging | $29,410 | 32 | 8.0% |
| Unspecified | $25,511 | 15 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,847 | 11 | 5.4% |
| Food and Beverage | $11,556 | 178 | 3.1% |
| Honoraria | $3,000 | 1 | 0.8% |
| Grant | $121.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $200,505 | 44 | $0 (2021) |
| Astellas Pharma Global Development | $31,672 | 15 | $0 (2020) |
| UROVANT SCIENCES INC | $27,108 | 12 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $19,369 | 10 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $18,317 | 9 | $0 (2018) |
| Astellas Pharma US Inc | $17,126 | 13 | $0 (2018) |
| Laborie Medical Technologies Corp. | $7,125 | 3 | $0 (2022) |
| Hologic, LLC | $6,875 | 5 | $0 (2020) |
| Axonics, Inc. | $5,564 | 14 | $0 (2024) |
| Medtronic, Inc. | $5,008 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,932 | 29 | Sumitomo Pharma America, Inc. ($4,059) |
| 2023 | $17,427 | 20 | Sumitomo Pharma America, Inc. ($15,310) |
| 2022 | $29,921 | 66 | UROVANT SCIENCES INC ($18,258) |
| 2021 | $25,786 | 21 | UROVANT SCIENCES INC ($8,850) |
| 2020 | $89,242 | 27 | Allergan, Inc. ($77,594) |
| 2019 | $111,300 | 41 | Allergan Inc. ($103,757) |
| 2018 | $61,725 | 63 | Merck Sharp & Dohme Corporation ($18,317) |
| 2017 | $24,602 | 32 | Astellas Pharma Global Development ($15,381) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 3 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2022 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Travel and Lodging | Cash or cash equivalent | $731.78 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 12/14/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $102.66 | General |
| Category: Urology | ||||||
| 12/13/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Continence Care | ||||||
| 12/06/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/17/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $5,403.60 | General |
| Category: Urology | ||||||
| 11/15/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: Continence Care | ||||||
| 11/08/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: Continence Care | ||||||
| 11/07/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: Continence Care | ||||||
| 11/04/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Continence Care | ||||||
| 11/01/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Continence Care | ||||||
| 10/24/2022 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Food and Beverage | Cash or cash equivalent | $102.82 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 10/18/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Continence Care | ||||||
| 10/18/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Continence Care | ||||||
| 10/12/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Interventional Urology | ||||||
| 10/11/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: Continence Care | ||||||
| 10/11/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Continence Care | ||||||
| 10/04/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: Continence Care | ||||||
| 09/16/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $6,004.00 | General |
| Category: Urology | ||||||
| 09/15/2022 | Boston Scientific Corporation | AdVance XP (Device) | Food and Beverage | In-kind items and services | $148.05 | General |
| Category: AdVance_URO | ||||||
| 09/15/2022 | Teleflex Medical Brasil Servicos E Comercio De Produtos Medicos Ltda | UroLift System (Device) | Food and Beverage | In-kind items and services | $44.21 | General |
| Category: Interventional Urology | ||||||
| 09/14/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Continence Care | ||||||
| 09/13/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Continence Care | ||||||
| 09/12/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $68.64 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/08/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/06/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Continence Care | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB | Astellas Pharma Global Development | $8,303 | 7 |
| A Prospective, Non-Interventional, Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder (OAB) | Astellas Pharma Global Development | $4,106 | 1 |
| Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB | Astellas Pharma Global Development | $3,195 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB | Astellas Pharma Global Development | $3,195 | 1 |
| TITAN 2 | Medtronic, Inc. | $3,144 | 2 |
| Penguin | Cytyc Surgical Products, LLC | $1,971 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB PERSPECTIVE | Astellas Pharma Global Development | $798.83 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) | Astellas Pharma Global Development | $798.67 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,768 | 1,972 | $948,814 | $119,541 |
| 2022 | 17 | 2,024 | 2,282 | $1.0M | $142,001 |
| 2021 | 23 | 2,249 | 2,599 | $1.2M | $158,012 |
| 2020 | 21 | 2,200 | 2,500 | $974,113 | $127,734 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 228 | $59,052 | $20,232 | 34.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 102 | 108 | $78,516 | $16,664 | 21.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 55 | 55 | $82,885 | $13,877 | 16.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 61 | 88 | $130,504 | $9,850 | 7.5% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 59 | 59 | $40,710 | $7,796 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 101 | 116 | $30,044 | $7,173 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $22,082 | $6,959 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 97 | $17,363 | $6,082 | 35.0% |
| 74455 | Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | Office | 2023 | 57 | 57 | $53,979 | $4,091 | 7.6% |
| 51600 | Injection procedure for imaging of bladder during voiding | Office | 2023 | 55 | 55 | $29,755 | $4,023 | 13.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 61 | 64 | $46,528 | $3,280 | 7.0% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 11 | 11 | $51,972 | $2,611 | 5.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 57 | 59 | $10,561 | $2,558 | 24.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 27 | 27 | $18,252 | $1,834 | 10.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,390 | $1,810 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,792 | $1,235 | 21.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 136 | 167 | $36,573 | $1,235 | 3.4% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 53 | 53 | $48,601 | $1,189 | 2.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,675 | $1,082 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 213 | 254 | $5,842 | $859.32 | 14.7% |
| 64590 | Insertion of peripheral or gastric neurostimulator generator | Facility | 2023 | 11 | 11 | $15,884 | $780.80 | 4.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 27 | 27 | $7,074 | $776.10 | 11.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 114 | 127 | $66,421 | $771.31 | 1.2% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 20 | 22 | $11,792 | $693.63 | 5.9% |
| 51705 | Simple change of bladder tube | Facility | 2023 | 17 | 24 | $11,856 | $557.32 | 4.7% |
About Dr. Eric Rovner, MD
Dr. Eric Rovner, MD is a Urology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841237013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Rovner, MD has received a total of $367,935 in payments from pharmaceutical and medical device companies, with $7,932 received in 2024. These payments were reported across 299 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($278,491).
As a Medicare-enrolled provider, Rovner has provided services to 8,241 Medicare beneficiaries, totaling 9,353 services with total Medicare billing of $547,289. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urogynecology and Reconstructive Pelvic Surgery
- Location Charleston, SC
- Active Since 05/31/2006
- Last Updated 10/20/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841237013
Products in Payments
- BOTOX (Drug) $77,117
- BOTOX (Biological) $71,639
- GEMTESA (Drug) $44,202
- BOTOX COSMETIC (Biological) $24,039
- MIRABEGRON (Drug) $20,606
- Myrbetriq (Drug) $15,381
- MYRBETRIQ (Drug) $12,810
- MK-7264 (Drug) $7,150
- Axonics r-SNM System (Device) $5,402
- Noctiva (Drug) $4,516
- BOTOX THERAPEUTIC - HH (Biological) $4,176
- NOCDURNA (Drug) $3,000
- INTERSTIM (Device) $2,568
- RENOVA $2,378
- BLUDIGO (Drug) $1,600
- eCoin Device Kit (Device) $894.70
- ACT (Device) $736.00
- Axonics (Device) $724.76
- Bulkamid (Device) $584.17
- AQUABEAM ROBOTIC SYSTEM (Device) $575.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Charleston
Dr. Sandip Prasad, Md, Mphil, MD, MPHIL
Urology — Payments: $102,389
Dr. Ian Marshall, M. D, M. D
Urology — Payments: $71,598
Dr. Thomas Keane, Md, MD
Urology — Payments: $70,386
Stephen Savage, Md, MD
Urology — Payments: $29,716
John Adams, Md, MD
Urology — Payments: $21,374
Dr. John Britton, M. D, M. D
Urology — Payments: $15,500